Rheumatoid arthritis treatment in 2026: what has changed
Early aggressive therapy, treat-to-target monitoring and biologics mean most newly diagnosed patients can expect a normal life. The modern RA playbook.
Rheumatologists, physiotherapists and exercise physiologists explain inflammatory arthritis, back pain and modern treatment — in plain language.
Stable follow-ups, medication reviews and flare triage work well by video. What telehealth does well in rheumatology — and what still needs hands on.
Early aggressive therapy, treat-to-target monitoring and biologics mean most newly diagnosed patients can expect a normal life. The modern RA playbook.
RA is first and foremost a joint disease — but fatigue, stiffness, nodules, dry eyes and bone loss are part of the picture too.
A delay of even a few months in starting DMARDs can mean substantially more joint damage. Why early, intensive therapy matters.
TNF inhibitors revolutionised AS management. For patients with persistent, debilitating symptoms the benefit greatly outweighs the risk.
Pain worse with rest and morning stiffness points to inflammation; pain with movement points to mechanical causes. Why the difference decides treatment.
The greatest risk of another osteoporotic fracture is having already had one. A simple fracture liaison service cuts re-fractures by 80%.
No better or worse than other modalities on average — but for the right patient, dry needling releases trigger points without painful hand pressure.